The recent ASCO guideline for immunotherapy diagnostics suggested MMR-IHC, MSI-PCR, and NGS for colorectal cancer, MMR-IHC and MSI-PCR for other GI tract cancers, and only MMR-IHC for endometrial cancer. The gene discussed is MRC1; the disease is endometrial cancer.